Your browser doesn't support javascript.
loading
NMDAR autoimmune encephalitis and fulminant relapse of multiple sclerosis: a rare overlap syndrome.
Douglass, Saxon; Field, Deborah.
Affiliation
  • Douglass S; Department of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia saxon@saxondouglass.com.
  • Field D; Department of Neurology, Royal Adelaide Hospital, Adelaide, SA, Australia.
BMJ Case Rep ; 17(7)2024 Jul 31.
Article in En | MEDLINE | ID: mdl-39089726
ABSTRACT
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disease that has been rarely associated with AQP4-IgG and MOG-IgG demyelinating diseases, and even more rarely with multiple sclerosis. We present the case of a woman in her 40s with confirmed NMDAR encephalitis and coexistent fulminant relapse of multiple sclerosis treated with alemtuzumab 6 years prior, who had a favourable outcome following treatment with ocrelizumab. We proceed to systematic review of similar reported cases, finding a lower than anticipated prevalence of underlying malignancy compared with isolated NMDAR encephalitis, in this rare overlap syndrome.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recurrence / Anti-N-Methyl-D-Aspartate Receptor Encephalitis Limits: Adult / Female / Humans Language: En Journal: BMJ Case Rep Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recurrence / Anti-N-Methyl-D-Aspartate Receptor Encephalitis Limits: Adult / Female / Humans Language: En Journal: BMJ Case Rep Year: 2024 Document type: Article Affiliation country: Country of publication: